Wells Fargo Reduces PT on Danaher Corporation (DHR) to $205; Maintains 'Equal Weight' Rating

With a year-to-date decline in share price, along with strong hedge fund interest, Danaher Corporation (NYSE:DHR) secures a place on our list of the 11 Best Rebound Stocks to Buy According to Hedge Funds.

On July 23, 2025, Wells Fargo reduced its price target on Danaher Corporation (NYSE:DHR) from $210 to $205, maintaining an ‘Equal Weight’ rating. This price revision follows the company’s quarterly results. DHR delivered a solid EPS beat and upward guidance revision during the quarter. Furthermore, the investment firm noted that the company held an additional $0.15-$0.20 per share in reserve.

Expectations for a robust recovery stemming from ongoing strength in the company’s Bioprocess segment further fueled the analyst’s optimism. Additionally, the Life Science segment is expected to record improvement in the second half of the year. At the same time, positive trends in the Pharma segment and growing momentum in China are driving analyst sentiment.

Danaher Corporation (NYSE:DHR) offers professional, medical, research, and industrial products and services with its Biotechnology, Life Sciences, and Diagnostics segments. It is included in our list of the Best Rebound Stocks To Buy.

While we acknowledge the potential of DHR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best AI Stocks to Buy Under $3 and Bill Ackman Stock Portfolio: Top 10 Stock Picks.

Disclosure: None.